Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Power3 Medical files patent apps for 47 protein biomarkers
March 2008
SHARING OPTIONS:

HOUSTON—Power3 Medical Products, Inc., a proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, filed a U.S. Utility Patent application for 47 protein biomarkers of neurodegenerative disease in human blood serum.
Power3 Medical has determined the blood serum concentrations of these 47 biomarkers in samples from more than 750 neurodegenerative disease patients and normal control subjects. The results have shown that this group of biomarkers is useful in the differential diagnosis of Alzheimer's disease (AD) from normal control individuals, patients with non-Alzheimer's dementias, and patients with Parkinson's disease or ALS (Lou Gehrig's disease). 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.